TearLab to Participate in the 11th Annual Craig-Hallum Institutional Investor Conference
21 Mai 2014 - 11:00PM
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the
"Company") announced today that its Chief Executive Officer, Elias
Vamvakas, will participate in the 11th Annual Craig-Hallum
Institutional Investor Conference on Wednesday, May 28, 2014. The
conference will be held at the Minneapolis Marriott City Center
Hotel.
The conference consists of a full day of one-on-one meetings and
will not be webcast. Investors interested in arranging one-on-one
meetings should contact their Craig-Hallum sales
representative.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and markets
lab-on-a-chip technologies that enable eye care practitioners to
improve standard of care by objectively and quantitatively testing
for disease markers in tears at the point-of-care. The TearLab
Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay
developed for the award-winning TearLab Osmolarity System.
Headquartered in San Diego, CA, TearLab Corporation's common shares
trade on the NASDAQ Capital Market under the symbol 'TEAR' and on
the Toronto Stock Exchange under the symbol 'TLB'.
Forward-Looking Statements
This press release may contain forward-looking statements. These
statements relate to future events and are subject to risks,
uncertainties and assumptions about TearLab. Examples of
forward-looking statements in this press release include statements
regarding our future recurring revenue expectations and our plans
for executing our marketing strategy and building a salesforce, the
future potential of the TearLab® Osmolarity System and the related
impact on our sales. These statements are only predictions based on
our current expectations and projections about future events. You
should not place undue reliance on these statements. Actual events
or results may differ materially. Many factors may cause our actual
results to differ materially from any forward-looking statement,
including the factors detailed in our filings with the Securities
and Exchange Commission and Canadian securities regulatory
authorities, including but not limited to our Annual Report on Form
10-K for the year ended December 31, 2013, filed with the SEC on
March 17, 2014, and our Quarterly Report on Form 10-Q for the
quarter ended March 31, 2014, filed with the SEC on May 9, 2014. We
do not undertake to update any forward-looking statements.
CONTACT: Stephen Kilmer
(647) 872-4849
skilmer@tearlab.com
Talbots (NYSE:TLB)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Talbots (NYSE:TLB)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Talbots (The) (New York Börse): 0 Nachrichtenartikel
Weitere News-Artikel